01 — The GTM Thesis
Lead with VZN. Deploy where resistance is lowest and outcomes are easiest to own.
The GTM strategy is simple: VZN. is the product, dental is the beachhead, and proof travels uphill from there. We do not go to market with an idea. We go to market with a fully operational operating model that already controls the variables that drive optical outcomes. Dental is first because it is an expansion play, not a turnaround. The practice is adding a new revenue stream with no legacy optical habits to unlearn, no broken frame board to unwind, and no in-house optical politics to fight through. That makes deployment cleaner, speed faster, and proof easier to produce. Once VZN. proves it can build profitable optical inside dental, that same proof becomes the wedge into larger eyecare groups that need optimization. Standalone OD comes later, after the proof stack is undeniable.
VZN. is the only active go-to-market product.
Dental practices adding vision are VZN. practice partners at Level 3, not DNTL.VZN customers.
The GTM order is dental first, multi-specialty eyecare second, standalone OD third.
DNTL. and DNTL.VZN matter strategically, but they are not what we sell today.
02 — Why Dental First
The first win is where the operating model fits naturally.
We started by approaching OD practices directly and learned the hard truth: existing optical operators resist change hard, especially when the message sounds like replacing habits they built over years. Dental changed the equation. A dentist with two practices wanted to add vision, and suddenly the model snapped into focus.
Expansion beats replacement
Dental is not being asked to fix a legacy optical model. They are adding one. That means less defensiveness, cleaner economics, and faster decision-making.
Clean slate operations
No inherited frame board, no stale product mix, no bad habits, and no underperforming optical culture to unwind. We deploy the model correctly from day one.
Team model already maps
The hygienist workflow maps cleanly to vision support roles. Dental teams already understand recurring care, patient education, and coordinated production flow.
Proof with less friction
Dental gives us the fastest path to clean outcome data: launch speed, patient uptake, optical capture, profit contribution, and owner confidence.
03 — Active Tracks
One active GTM engine. Two entry stories. One future roadmap behind it.
VZN. for Dental
Beachhead GTM motion for dental practices adding vision as a new revenue stream.
This is the primary deployment path right now. The pitch is expansion: add a fully deployed vision operating model without having to invent optical from scratch.
- Audience: growth-minded dental owners and groups
- Positioning: new revenue stream, new patient value, clean-slate deployment
- Why now: lowest resistance and fastest proof generation
VZN. for Eyecare
Same VZN. operating model, positioned for existing eyecare operators who need optimization.
This is not a different product. It is the same operating model entering through a different story: fix what is underperforming, simplify what is overcomplicated, and drive better optical and business outcomes.
- Audience: multi-specialty eyecare groups, OMD/OD organizations, established optical operators
- Positioning: optimization, margin recovery, workflow control, owner visibility
- Why second: requires proof because incumbent habits create resistance
DNTL.
Strategic future state under development. Not a current go-to-market offer.
DNTL. belongs in roadmap context only. It is not the product being sold, pitched, or positioned in front of the market right now.
- Not active GTM
- Not the lead narrative
- Relevant to long-range platform expansion only
DNTL.VZN
Future-state brand idea, not a live product and not a current customer category.
Dental practices adding vision today should be understood as VZN. partners at Level 3. We do not create confusion by pretending DNTL.VZN already exists in market.
- Does not exist yet as a product
- Do not lead with it in GTM
- Use only as roadmap context when appropriate
04 — The Outcome Model
We do not sell lenses. We deliver outcomes.
VZN. can own outcome language because VZN. owns the operating variables that labs and vendors usually leave behind. This is not a wholesale relationship. It is a vertically integrated operating model deployed inside the practice.
Commercial stack
Optical stack
Clinical and operational stack
Because the stack is integrated, VZN. can take responsibility for the result. That is the difference. Vendors sell components. VZN. deploys an operating model.
05 — One Brand, Two Entry Stories
Same operating model. Different buyer pain.
VZN. for Dental
Expansion playWho
Dental practice owners and groups looking to add vision without building optical from scratch.
Why it works
They are not defending a legacy optical department. They are adding a new line of business with a clean operating foundation.
The pitch
Deploy a vision operating model inside your dental practice that creates a new revenue stream, expands patient value, and gives ownership clear visibility into performance.
VZN. for Eyecare
Optimization playWho
Multi-specialty eyecare groups, OMD/OD organizations, and operators with existing optical that is underperforming or operationally sloppy.
Why it works
They already have patients, staff, and volume. What they lack is a disciplined operating model that controls product mix, workflow, promotions, and owner economics.
The pitch
Deploy VZN. to tighten the optical engine you already have, improve profitability, raise consistency, and turn optical from a tolerated department into a managed outcome.
06 — Proof Point Cascade
Each market unlocks the next one.
Dental practices
Use dental as the clean-slate proving ground. Show that VZN. can deploy quickly, train teams effectively, generate optical revenue, and create measurable profit contribution inside a non-traditional setting.
Multi-specialty eyecare groups
Use dental proof to disarm skepticism and show that the operating model works because it controls the economics, workflow, merchandising, and patient experience end to end.
Standalone OD practices
Enter only after the proof stack is mature enough to overcome the highest-resistance buyer. Solo ODs are the hardest audience because they are closest to legacy habits and most likely to interpret change as identity threat.
This is why sequencing matters. We are not avoiding eyecare. We are earning the right to win it with better proof.
07 — Roadmap Context
Keep the future visible without confusing the present.
NXTLVL. is the company umbrella, not the current product. VZN. is the operating model going to market now. DNTL. is a future concept in development. DNTL.VZN is a future roadmap expression, not a live category, not an active offer, and not something the market should hear before VZN. proof is fully established. The strategic mistake would be letting future architecture blur current execution.
NXTLVL.
Company umbrella and strategic parent context.
VZN.
Current active product and only live GTM motion.
DNTL.
Future concept in development. Not currently sold.
DNTL.VZN
Future roadmap only. Does not exist yet as a product.
08 — What We Are Not Doing
Clarity comes from what we refuse to confuse.
We are not taking DNTL.VZN to market before it exists.
We are not describing dental practice partners as a separate product category when they are VZN. partners deploying at Level 3.
We are not leading with future architecture when current execution is the job.
We are not waiting for every roadmap track to finish sequentially before selling VZN. now.
We are not positioning VZN. like a lab, vendor, or commodity supplier.
We are not asking the market to believe theory. We are showing a deployed operating model with owned outcomes.
North Star
Build proof where the model fits fastest, then use that proof to climb the market. VZN. wins because it controls the stack, owns the outcome, and enters through the buyer story with the least resistance first.
First dental. Then multi-specialty eyecare. Then standalone OD. One operating model all the way through.